Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $207.20 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $62.65 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $33.36 | 2 | $0 (2018) |
| Octapharma USA, Inc. | $33.04 | 1 | $0 (2024) |
| Spectrum Pharmaceuticals Inc. | $30.81 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $25.83 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $21.51 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.04 | 1 | Octapharma USA, Inc. ($33.04) |
| 2018 | $97.07 | 7 | Merck Sharp & Dohme Corporation ($33.36) |
| 2017 | $77.09 | 5 | Incyte Corporation ($62.65) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | Octapharma USA, Inc. | BALFAXAR (Biological) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: INTENSIVE CAREEMERGENCY | ||||||
| 09/05/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2018 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2018 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/16/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Oncology | ||||||
| 12/15/2017 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Not Applicable | ||||||
| 09/15/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.42 | General |
| Category: Hematology/Oncology | ||||||
| 04/20/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Hematology/Oncology | ||||||
| 02/22/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $11.73 | General |
| Category: Hematology/Oncology | ||||||
| 01/30/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: Hematology/Oncology | ||||||
About Edward Samuel, MD, PHD
Edward Samuel, MD, PHD is a Hematology & Oncology healthcare provider based in E Setauket, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730183302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edward Samuel, MD, PHD has received a total of $207.20 in payments from pharmaceutical and medical device companies, with $33.04 received in 2024. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($207.20).
Practice Information
- Specialty Hematology & Oncology
- Location E Setauket, NY
- Active Since 06/10/2005
- Last Updated 03/24/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1730183302
Products in Payments
- JAKAFI (Drug) $62.65
- KEYTRUDA (Biological) $33.36
- BALFAXAR (Biological) $33.04
- Zevalin (Drug) $30.81
- JEVTANA (Drug) $25.83
- XARELTO (Drug) $21.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.